20″ March “2022” https://www.nbcnews.com
Ma la gaadhay waqtigii tallaalka xoojin lahaa ee Covid-19 kale? Pfizer-BioNTech iyo Moderna waxay u muuqdaan inay sidaas u malaynayaan, laakiin khubarada tallaalka qaarkood si dhab ah uma hubo., whether it should be a new shot and only for certain groups.
Codsiyada dawo-sameeyayaasha ee qiyaas afraad, oo loo gudbiyay Maamulka Cuntada iyo Dawooyinka toddobaadkan, waxay u badan tahay inay ku sii kordhiyaan dooda saynisyahannada ku saabsan haddii qiyaas tallaal oo dheeraad ah ay lagama maarmaan tahay iyo haddii ay sidaas tahay, inay noqon doonto tallaal cusub iyo in kale. kooxo gaar ah oo kaliya Pfizer and BioNTech asked the FDA
Full coverage of the Covid-19 pandemic
Dhaqdhaqaaqa ayaa imanaya iyada oo ay jiraan calaamado hore oo muujinaya in Maraykanku uu dhawaan la kulmi karo mowjad kale oo Covid ah sida micron subvariant, oo loo yaqaan BA.2, ku fida Yurub oo dhan iyo qaybaha kale ee adduunka. Waddamada kale, oo ay ku jiraan Chile, Israa’iil iyo Iswidhan, ayaa horeba u oggolaaday tallaalka afraad ee dadka nugul qaarkood.
Pfizer iyo BioNTech waxay waydiisteen FDA Talaadadii inay oggolaadaan tallaalka labaad ee xoojiya dadka da’doodu tahay 65 iyo wixii ka weyn, halka Moderna ay ka codsatay wakaaladda Khamiista inay oggolaato xoojiye labaad dhammaan dadka waaweyn, amid early signs
Cilmi baaristu waxay muujineysaa in ilaalinta labada qiyaasood ee ugu horreeya midkood Pfizer ama tallaalka Moderna ay si weyn uga dhimmatay kala duwanaanshaha omicron, in kasta oo tallaalka xoojinta ay soo celisay inta badan ilaalintaas. Laakiin maamulayaasha Pfizer iyo Moderna ayaa ku dooday toddobaadyadii la soo dhaafay in qiyaas afaraad laga yaabo in hadda loo baahdo si looga ilaaliyo jirrooyinka halista ah ee omicron the omicron subvariant, known as BA.2,
Si loo hubiyo, caddaynta ay dawo-bixiyeyaasha la wadaageen maaha wax kasta oo ku qasbaya saynisyahannada qaarkood, ayuu yidhi Dr. Jesse Goodman oo ka tirsan Jaamacadda Georgetown, oo ah madaxii hore ee tallaalka FDA.
Mid ka mid ah daraasadaha, ay daabacday bishii Febraayo oo ay daabacday Xarunta Xakamaynta iyo Kahortagga Cudurrada, waxay ogaatay in waxtarka tallaallada Pfizer’s iyo Moderna ee ka dhanka ah isbitaallada ay hoos uga dhacday 91 boqolkiiba laba bilood ka dib tallaalka xoojinta bilowga ah ilaa 78 boqolkiiba afar bilood ka dib. Daraasad kale, sida laga soo xigtay Pfizer siidaynta wararka, waxay ogaatay in heerarka jirada daran ay afar jeer ka hooseeyaan shakhsiyaadka helay qiyaasta labaad ee tallaalka, marka la barbar dhigo kuwa la siiyay hal tallaal oo xoojin ah.in The New England Journal of Medicine
Goodman wuxuu sheegay in ka-hortagga jirrada daran ee qiyaasta saddexaad ay u muuqato mid sii kordheysa. Isagu “kuma qanacsana” in kobcinta heerarka antibody-ka ee qiyaasta afraad ay u tarjumi doonto ilaalin xooggan.
Daraasad lagu daabacay Arbacadii gudaha The New England Journal of Medicine waxaa lagu ogaadey in qiyaasta afaraad aysan muujin kala duwanaansho la taaban karo ee heerarka unugyada difaaca jirka ee lidka ku ah kala duwanaanshaha omicron, marka la barbar dhigo qiyaasta saddexaad. Daraasadaas, oo ka socota cilmi-baarayaasha Israa’iil, waxay eegtay in ka badan 800 oo shaqaale caafimaad oo da’yar oo caafimaad qaba.
Waxaa suurtogal ah in qiyaaso dheeraad ah loogu baahdo kooxaha qaarkood, sida dadka waaweyn, mustaqbalka, in kasta oo ay aad goor hore tahay in la sheego, ayay tidhi Dr. Anna Durbin, oo ah cilmi-baare tallaal oo ka tirsan Jaamacadda Johns Hopkins.
Tani waxay hoos ugu dhacday dood ku saabsan waxa aan fileyno in tallaalku sameeyo.
“Covid waxay u badan tahay inuu halkaan sii joogo. Waxaan sii wadi doonaa inaan cudurku sii qaadno sannad kasta, sida aan u qabno caabuqyada hargabka sannadkii,” ayay tidhi. “Waxa loo baahan yahay calaamad muujinaysa tallaallada soo noqnoqda w壯陽藥 aa darnaanta cudurka.”
John Moore, oo ah borofisar ku takhasusay microbiology iyo immunology oo ka tirsan Weill Cornell Medicine, ayaa sheegay in marka FDA iyo lataliyayaasheeda ay kulmaan, ay u baahan doonaan inay go’aansadaan nooca ilaalinta ay ka filayaan tallaallada.while Moderna asked the agency
Guddiga tallaalka FDA ee khubarada dibadda, oo loo yaqaan Tallaalka iyo Guddiga La-talinta Alaabooyinka Bayoolojiga ee La Xidhiidha, ayaa loo qorsheeyay inay kulmaan toddobaadka ugu horreeya ee Abriil si ay uga wada hadlaan tallaallada xoojiya, dadka aqoonta u leh qorshaha wakaaladda ayaa yidhi.
“Tani waxay hoos ugu dhacday dood ku saabsan waxa aan fileyno in tallaallada la sameeyo,” ayuu yiri Moore. “Laba qiyaasood ayaa wali qabanaya shaqo aad u wanaagsan oo ay dadka ka ilaalinayaan inay si xun u jiran oo ay u dhintaan
Qaadashada Qiyaasata 4 aad Maxay Ku Kordhineeysaa Difaaca Jirka ?
Soo gudbinta Moderna ee xoojin Afraad oo la mid ah isla qaacido ayaa imanaysa toddobaadyo uun ka dib markii sarkaalkeeda caafimaadka, Dr. Paul Burton, u sheegay NBC News in tallaalka Covid ee la cusboonaysiiyay loo baahan doono dayrta, mid “la jaanqaadaya isku dhafka saxda ah ee noocyada kala duwan. ”
Dhab ahaantii, tallaalada Pfizer iyo Moderna ee horumarinta kuwaas oo lagu beegsanayo kala duwanaanshaha omicron ayaa laga yaabaa inay qabtaan shaqo xitaa ka sii fiican, laakiin Moore wuxuu sheegay in xogta hore ay soo jeedinayso habka uusan ahayn mid rajo leh.
Daraasad xayawaan ah, lagu dhajiyay online oo lagu dhejiyay server-ka hore bishii Febraayo, ayaa soo jeedisay in tallaalka xoojinta gaar ah ee omicron uusan bixin karin ilaalin ka weyn marka la barbardhigo kuwa xoojiyayaasha jira. Daraasada, oo ka timid saynisyahano ka tirsan Machadka Qaranka ee Xasaasiyadda iyo Cudurada Infekshinka, ayaa eegay muunado dhiig ah oo laga soo qaaday xayawaannada hore ee lagu xoojiyay tallaal ku saleysan omicron ama qaabka asalka ah ee coronavirus.posted online to a preprint server